BlackRock’s Monopar Therapeutics MNPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.3M Buy
316,567
+61,710
+24% +$3.73M ﹤0.01% 3169
2025
Q4
$16.6M Buy
254,857
+51,106
+25% +$4.18M ﹤0.01% 3183
2025
Q3
$16.6M Sell
203,751
-1,418
-0.7% -$63.4K ﹤0.01% 3196
2025
Q2
$7.34M Buy
205,169
+190,705
+1,318% +$6.93M ﹤0.01% 3570
2025
Q1
$527K Buy
14,464
+6,363
+79% +$229K ﹤0.01% 4380
2024
Q4
$178K Buy
+8,101
New +$136K ﹤0.01% 4646
2022
Q3
Sell
-465
Closed -$5K 5883
2022
Q2
$5K Sell
465
-2,278
-83% -$25.8K ﹤0.01% 5682
2022
Q1
$35K Sell
2,743
-112
-4% -$1.66K ﹤0.01% 5482
2021
Q4
$46K Buy
2,855
+62
+2% +$1.38K ﹤0.01% 5417
2021
Q3
$68K Sell
2,793
-216
-7% -$5.59K ﹤0.01% 5235
2021
Q2
$89K Buy
3,009
+763
+34% +$21.8K ﹤0.01% 5082
2021
Q1
$70K Buy
2,246
+1,168
+108% +$42.6K ﹤0.01% 4880
2020
Q4
$33K Buy
1,078
+537
+99% +$13.9K ﹤0.01% 4722
2020
Q3
$14K Sell
541
-185
-25% -$5.98K ﹤0.01% 4763
2020
Q2
$27K Buy
726
+165
+29% +$6.34K ﹤0.01% 4654
2020
Q1
$20K Buy
+561
New +$35.1K ﹤0.01% 4622

Other funds holding MNPR